JBM (Healthcare) Limited

2161

KYG1090B1077

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:22 2024-04-29 am EDT			5-day change	1st Jan Change
0.88 ^HKD	0.00%		-2.22%	-16.19%

Apr. 02	JBM Group Group Limited Announces Revision of the Existing Annual Caps for the Continuing Connected Transactions Under the 2023 Manufacturing Services Agreement	CI
Mar. 08	JBM Limited Announces Board Changes, Effective 9 March 2024	CI

JBM Limited Announces Interim Dividend for the Six Months Ended 30 September 2023, Payable on 28 December 2023

November 22, 2023 at 05:21 am EST

JBM (Healthcare) Limited announced interim dividend of HKD 0.0345 per share for the six months ended 30 September 2023. Record date is 12 December 2023, Payment date is 28 December 2023 and Ex Dividend date is 07 December 2023.

Latest news about JBM (Healthcare) Limited

JBM Group Group Limited Announces Revision of the Existing Annual Caps for the Continuing Connected Transactions Under the 2023 Manufacturing Services Agreement	Apr. 02	CI
JBM Limited Announces Board Changes, Effective 9 March 2024	Mar. 08	CI
JBM Limited Announces Change of Company Secretary	Nov. 22	CI
JBM (Healthcare) Hikes Dividend as Six-Month Profit Soars 189%	Nov. 22	MT
JBM Limited Announces Interim Dividend for the Six Months Ended 30 September 2023, Payable on 28 December 2023	Nov. 22	CI
JBM Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 22	CI
JBM (Healthcare) Forecasts Threefold Jump in Fiscal H1 Profit	Nov. 07	MT
JBM Limited Provides Group Earnings Guidance for the Six Months Ended 30 September 2023	Nov. 07	CI
JBM Limited commences an Equity Buyback Plan for 91,368,600 shares, representing 10% of its issued share capital, under the authorization approved on August 1, 2023.	23-08-29	CI
JBM Limited Approves Final Cash Dividend for the Year Ended March 31, 2023	23-08-01	CI
JBM (Healthcare)'s FY23 Attributable Profit More Than Doubles	23-06-15	MT
JBM Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-15	CI
JBM Limited Proposes Final Dividend for the Financial Year End 31 March 2023, Payable on 01 September 2023	23-06-15	CI
JBM (Healthcare) Expects 130% Rise in FY23 Attributable Profit	23-05-31	MT
JBM Limited Provides Earnings Guidance for the Year Ended 31 March 2023	23-05-31	CI
JBM Limited completed the acquisition of remaining 50% stake in Five Ocean Inc. from Million Effort Investment Limited for HKD 19 million.	23-03-22	CI
JBM Healthcare to Take Full Ownership of Chinese Medicines JV	23-03-21	MT
JBM Group Limited agreed to acquire the remaining 50% stake in Five Ocean Inc. from Million Effort Investment Limited for HKD 17 million.	23-03-16	CI
JBM Healthcare's Profit for Six Months Through September Doubles	22-11-27	MT
JBM Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-25	CI
JBM Limited Declares Interim Dividend for the Six Months Ended 30 September 2022, Payable on 29 December 2022	22-11-25	CI
JBM (Healthcare) Expects Up to 120% Increase in April-September Profit; Shares Rally 12%	22-11-02	MT
JBM Limited Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Six Months Ended 30 September 2022	22-11-02	CI
JBM Limited Announces Change of Headquarters and Principal Place of Business in Hong Kong	22-09-09	CI
JBM Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-06-29	CI

Chart JBM (Healthcare) Limited

Duration

Period

More charts

Company Profile

JBM Healthcare Ltd is an investment holding company mainly engages in the marketing and distribution of proprietary Chinese medicines. The Company operates its business through three segments. The Proprietary Chinese Medicines segment mainly distributes over the counter (OTC) proprietary Chinese medicines and concentrated Chinese medicine granule (CCMG) products. The Consumer Healthcare Products segment primarily distributes proprietary medicines in the form of OTC. The Health and Wellness Products segment sales and distributes health and wellness products. The Company operates business in domestic and overseas markets such as Southeast Asia, Europe, and North America.

Sector

Pharmaceuticals

Calendar

2024-06-25 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
JBM (HEALTHCARE) LIMITED	-16.19%	93.08M
DONG-E-E-JIAO CO.,LTD.	+35.04%	5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B

Alternative Medicine

JBM (Healthcare) Limited

Equities

2161

KYG1090B1077

Pharmaceuticals

JBM Limited Announces Interim Dividend for the Six Months Ended 30 September 2023, Payable on 28 December 2023

Latest news about JBM (Healthcare) Limited

Chart JBM (Healthcare) Limited

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Alternative Medicine